Plicamycin

普卡霉素

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePlicamycin
Drug Alias NameMithramycin光神霉素Plicamycine光辉霉素普卡酶素 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsHypercalcemiaThymus NeoplasmsLung Neoplasms +[10] 
Global Approved IndicationsHypercalcemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1970/05/05
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsHypercalcemiaThymus NeoplasmsLung Neoplasms +[10] 

Other Information

ATC CodeL01DC02
Related LinksWikipediaDrugBankKEGG